Traduction de «à l'examen diamètre pupillaire » (Français → Anglais) :

O/E - pupil size

O/E - pupil reaction

(5) For the purpose of 4.5.1 of the Timber Code, if, when a visual examination under 4.5.3 of the Timber Code or section 138 is made, the diameter of a section of a lashing or component appears to be reduced by 5% or more from its original diameter, any certificate issued in respect of the lashing or component is invalid unless

(x) all steering gear leads shall be dismantled to permit of a detailed examination of all parts; where any length of chain is so worn that the diameter at any part is reduced to the size shown in Schedule IV, that part shall be renewed; all replacements of steering gear chain, or chain that has been repaired, shall be subjected to the proof and breaking tests specified in Schedule II or III; these tests shall be carried out by an authority approved by the Board and certificates of tests shall be furnished;

Again, that would typically be with smaller-diameter pipelines.

Question No. 53 Ms. Kirsty Duncan: With respect to the chronic cerebrospinal venous insufficiency (CCSVI) clinical trial being undertaken by Dr. Traboulse: (a) what milestones are reportable to the government, (i) on what date(s) is reporting expected to occur, (ii) how will this information be communicated to patients, the medical community, and the general public; (b) on what date did each of the trial sites pass ethical review; (c) on what date did recruitment of patients begin for each of the trial sites; (d) how many patients with multiple sclerosis (MS) are being recruited for each site, and how is consistency in diagnosis and treatment being ensured across sites; (e) who is performing the diagnoses for CCSVI for each site, (i) ho ...[+++]w is the diagnosis being performed, including, but not limited to, ultrasound and venogram, (ii) how many diagnoses has each person undertaking the diagnosis at each site performed prior to the study, and by whom was each person trained; (f) who is performing the procedures for each site, (i) how is the procedure being performed, including, but not limited to, anesthetic, balloon size, (ii) how many procedures has each person undertaking the procedure at each site performed prior to the study, and by whom was each person trained; (g) what are the selection criteria for the trial, including, but not limited to, type of MS, Expanded Disability Status Scale (EDSS) score, venous abnormality/malformed valve/stenosis, mobility, (i) how do these criteria compare with the international literature, (ii) with how many international studies to date will the selection criteria be analytically comparable; (h) if both progressive and relapsing-remitting forms of MS are to be examined in the trial, how will statistical significance be ensured given that 50 of 100 patients will undergo a “sham” procedure, 25 patients will have a progressive form of the disease, and 25 will have a relapsing-remitting form of the disease, and will people with bo ...